https://www.selleckchem.com/pr....oducts/enarodustat.h
Aim We aimed to explore the biomarkers for disease progression or the risk of nonsurvivors. Materials methods This study included 134 hospitalized patients with confirmed COVID-19 infection. The outcome of moderate versus severe versus critically ill patients and survivors versus nonsurvivors were compared. Results An increase in the severity of COVID-19 pneumonia was positively associated with lower levels of platelets and albumin (all p less then 0.05). In the critical group, the plasma levels of albumin continued to have a
Beğen
Yorum Yap
Paylaş
